SCHEMBL2522348

SCHEMBL2522348

c1ccc2c(c1)Cc1ccc([N]c3ccc4c(c3)-c3ccccc3C4)cc1-2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
MAPT P10636 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.52
KDM4E B2RXH2 2/20 0.52
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
HPGD P15428 2/20 0.52
LMNA P02545 1/20 0.52
CYP1A2 P05177 6/20 0.48
CYP3A4 P08684 5/20 0.47
CYP2C19 P33261 3/20 0.47
CYP2C9 P11712 2/20 0.46
SRD5A2 P31213 1/20 0.46
MAOA P21397 2/20 0.45
PGR P06401 2/20 0.44
HTR2C P28335 2/20 0.42
HTR2B P41595 2/20 0.42
DRD2 P14416 1/20 0.42
ADRA1D P25100 1/20 0.42
HTR2A P28223 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2168127 0.92 SMN1; SMN2 (0.57) ALDH1A1MAPTSMN1; SMN2KDM4ENPC1
SCHEMBL2165572 0.86 CYP1A2 (0.55) ALDH1A1MAPTSMN1; SMN2KDM4ENPC1
SCHEMBL30912172 0.82 SMN1; SMN2 (0.64) ALDH1A1MAPTSMN1; SMN2KDM4ENPC1
SCHEMBL5058433 0.82 SMN1; SMN2 (0.64) ALDH1A1MAPTSMN1; SMN2KDM4ENPC1
SCHEMBL18582934 0.82 SMN1; SMN2 (0.64) ALDH1A1MAPTSMN1; SMN2KDM4ENPC1
SCHEMBL5016641 0.82 SMN1; SMN2 (0.64) ALDH1A1MAPTSMN1; SMN2KDM4ENPC1
SCHEMBL3280539 0.80 SMN1; SMN2 (0.61) ALDH1A1MAPTSMN1; SMN2KDM4ENPC1
SCHEMBL29924230 0.80 SMN1; SMN2 (0.61) ALDH1A1MAPTSMN1; SMN2KDM4ENPC1
SCHEMBL2720506 0.77 ALDH1A1 (0.70) ALDH1A1MAPTSMN1; SMN2KDM4ENPC1
Fluorene SCHEMBL31388525 0.76 MAOA (0.68) ALDH1A1MAPTSMN1; SMN2KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8039128-B2 Fluorene compound, organic light emitting device and display device using the fluorene compound CANON KABUSHIKI KAISHA (JP) 2011-10-18 US disclosed
US-20100072885-A1 FLUORENE COMPOUND, ORGANIC LIGHT EMITTING DEVICE AND DISPLAY DEVICE USING THE FLUORENE COMPOUND CANON KABUSHIKI KAISHA (JP) 2010-03-25 US disclosed
WO-2008146825-A1 FLUORENE COMPOUND, ORGANIC LIGHT EMITTING DEVICE AND DISPLAY DEVICE USING THE FLUORENE COMPOUND CANON KABUSHIKI KAISHA (JP) 2008-12-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100072885-A1 FLUORENE COMPOUND, ORGANIC LIGHT EMITTING DEVICE AND DISPLAY DEVICE USING THE FLUORENE COMPOUND ARL1, AFF1, AFF2 ALDH1A1 165/4885MAPT 3257/4885SMN1; SMN2 3419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.